General Information of This Drug (ID: DM3OMDV)

Drug Name
XL-888   DM3OMDV
Synonyms SCHEMBL17313415; QC-9274
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
XL-888 + Panobinostat DCKC8BB Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
XL-888 + Marizomib DC5HTTC Marizomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00796484) Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors. U.S. National Institutes of Health.
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.